1. What is the CreoSG Rights Offering?

On September 3, 2025, CreoSG announced a ₩1 billion rights offering. The offering involves 1,999,999 common shares at an issue price of ₩500 per share, with ND Engineering as the main investor.

2. Why the Rights Offering?

CreoSG operates three business segments: Solutions, Bio, and Real Estate. The Solutions business is struggling, and the Bio segment has yet to generate revenue. The rights offering aims to secure funding for R&D in the Bio segment and improve the company’s financial structure.

3. How Will the Offering Impact the Stock Price?

  • Positive Impact: Increased investment in the Bio segment and improved financial health.
  • Negative Impact: Potential dilution of existing shareholder value due to the low offering price of ₩500.

Short-term volatility is expected, while the long-term stock performance hinges on the success of the Bio segment’s R&D efforts.

4. What Should Investors Do?

Consider the following before making investment decisions:

  • Changes in financial health after the offering
  • Recovery of the Solutions business and tangible results from the Bio segment
  • Shifts in macroeconomic indicators and the competitive landscape